Randomized Trial of Adjuvant Radiotherapy with or without Cisplatin for p53 Mutated, Surgically Resected Squamous Cell Carcinoma of the Head and Neck (EA3132)
Randomized Trial of Adjuvant Radiotherapy with or without Cisplatin for p53 Mutated, Surgically Resected Squamous Cell Carcinoma of the Head and Neck (EA3132)
Trial Category:
Head and Neck
Phase
II
Contact(s)
Location(s)
Faith Regional Health System, Carson Cancer Center, Norfolk, NE
Great Plains Health, Callahan Cancer Center, North Platte, NE
Nebraska Cancer Specialists, Omaha, NE
Nebraska Hematology Oncology, Lincoln, NE
Regional West Health Services, Cancer Center, Scottsbluff, NE
Southeast Nebraska Cancer Center, Lincoln, NE
This study is looking at Radiation Alone vs Radiation Plus Chemotherapy with the drug Cisplatin for head and neck tumors. Patients are "randomized" on this study. This means a computer tells the study team which treatment you will receive. Neither the patient or the physician can choose the treatment assignment. The purpose of Randomized trials is to equally study all treatment options using the same criteria in order to identify if one treatment may be superior to another treatment.
